Viveve Medical Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS

Ticker Exchange SIC # Website Latest Ticker
VIVE Nasdaq 3845 https://us.viveve.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Viveve Medical Inc

Edited Transcript of VIVE earnings conference call or presentation 9-May-19 9:00pm GMT - Jun 13th, 2019 1:27 pm
Viveve to Present at Raymond James Life Sciences and MedTech Conference - Jun 11th, 2019 6:28 am
VIVE: Q1 Results: Restructuring Dramatically Improves Op Loss. $20M Sales Guidance Intact. SUI Data Read-Out This Summer - May 24th, 2019 7:00 am
Viveve Reports First Quarter 2019 Financial and Operating Results - May 9th, 2019 2:02 pm
Viveve to Host Conference Call to Discuss First Quarter 2019 Financial and Operating Results on May 9, 2019 - May 2nd, 2019 6:28 am
The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug - Apr 12th, 2019 5:47 am
Viveve Announces CE Mark Clearance for its Next Generation 2.0 Platform in the European Union - Apr 11th, 2019 2:02 pm
VIVE: Warning Letter Headwinds Persist, Although Dissipating. 2019 Guidance Implies Much-Improved Operating Loss - Mar 20th, 2019 8:45 am
Edited Transcript of VIVE earnings conference call or presentation 14-Mar-19 9:00pm GMT - Mar 19th, 2019 7:59 pm
Viveve Medical Inc (VIVE) Files 10-K for the Fiscal Year Ended on December 31, 2018 - Mar 15th, 2019 9:48 pm
Viveve Reports Fourth Quarter and Full Year 2018 Financial Results - Mar 14th, 2019 2:02 pm
The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering - Mar 14th, 2019 5:47 am
Viveve Completes Enrollment in VIVEVE II Trial - Mar 11th, 2019 6:26 am
Viveve to Host Conference Call to Discuss Fourth Quarter and Year-end 2018 Financial Results and Corporate Update on March 14, 2019 - Mar 7th, 2019 6:26 am
Viveve to Present at Cowen and Company 39th Annual Health Care Conference - Mar 5th, 2019 6:26 am
VIVE: Q4 Preannouncement, 2019 Guidance / Strategic Restructuring - Jan 21st, 2019 9:15 am
Viveve Reports Preliminary Full Year 2018 Financial Results, Announces 2019 Revenue Guidance and Provides Corporate Update - Jan 16th, 2019 6:28 am
Viveve Completes Enrollment in LIBERATE-International Trial for Improvement of Stress Urinary Incontinence - Jan 3rd, 2019 6:28 am
VIVE: 12-Month SUI Feasibility Study Data Further Supports Compelling Efficacy Signal - Dec 24th, 2018 7:30 am
Viveve Announces FDA Clearance to Advance VIVEVE II Clinical Study to Full Enrollment - Dec 20th, 2018 2:50 pm